跳至主要内容
临床试验/JPRN-UMIN000001649
JPRN-UMIN000001649尚未招募4 期

The evaluation of efficacy and safety in modification to new immunosuppressant (tacrolimus hydrate:Graceptor) from the current immunosuppressive therapy after liver transplantation - The evaluation of efficacy and safety in modification to new immunosuppressant (tacrolimus hydrate:Graceptor) from the current immunosuppressive therapy after liver transplantation

Graduate School of Medicine, Osaka University Department of Surgery0 个研究点目标入组 20 人开始时间: 2014年1月31日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1clinicopathologically diagnosed with rejection in recent 90 days . 2underwent rejection treatment in recent 6 months 3diagnosed with rejection beyond twice in 12 months 4liver dysfunction ,AST>=40, or ALT>=40 5Drug user of cross interaction with Tacrolimus 6Other severe concomitant disease or medical conditions. 7drug abuser, mentally unstable recipient, The patient who was judged to have difficulty in communication with the doctor 8History of contraindication to tacrolimus. 9A pregnant woman or a woman with possibility becoming pregnant 10severe renal dysfunction 11Inappropriate patients for entry on this trial in the judgement of the investigator

研究者

发起方
Graduate School of Medicine, Osaka University Department of Surgery

相似试验